Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

CDP is crucial for lung and hair follicle cell development.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Blood vessels and specific genes help turn cartilage into bone when bones heal.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogen therapy can reduce skin aging but has cancer risks.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

PEVs improve minoxidil skin penetration, increasing hair growth.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Different PIN proteins affect plant root hair growth by changing how auxin is transported.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.